Medical Journals

Role of Nuclear Factor-kappab in Interleukin-1-induced Collagen Degradation by Corneal Fibroblasts.

Authors:
  • Lu Ying
  • Fukuda Ken
  • Li Qin
  • Kumagai Naoki
  • Nishida Teruo

From: Department of Biomolecular Recognition and Ophthalmology, Yamaguchi University School of Medicine, 1-1-1 Minami-Kogushi, Ube City, Yamaguchi 755-8505, Japan.

Experimental eye research

  • Publish Date: Sep 2006
  • ISSN: 0014-4835
  • Volume: 83
  • Issue: 3
  • Pages: 560-8
  • Medium: Print
  • Language: English
  • Citation (JAMA): Lu Ying, Fukuda Ken, Li Qin, et al. Role of Nuclear Factor-kappab in Interleukin-1-induced Collagen Degradation by Corneal Fibroblasts.. Exp. Eye Res. Sep 2006;83:560-8

Abstract

The proinflammatory cytokine interleukin (IL)-1 is implicated in corneal ulceration. The role of nuclear factor (NF)-kappaB in the IL-1-induced degradation of collagen by corneal fibroblasts that underlies corneal ulceration was investigated. Rabbit corneal fibroblasts were cultured in three-dimensional gels of type I collagen with or without IL-1 and sulfasalazine, an inhibitor of NF-kappaB activation. Collagen degradation was assessed from the amount of hydroxyproline generated by acid-heat hydrolysis of culture supernatants. The release of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) into culture supernatants was examined by immunoblot analysis and gelatin zymography, and the cellular abundance of MMP and TIMP mRNAs was determined by reverse transcription and real-time polymerase chain reaction analysis. The phosphorylation and degradation of the NF-kappaB-inhibitory protein IkappaB-alpha were examined by immunoblot analysis. The subcellular localization and DNA binding activity of the p65 subunit of NF-kappaB were evaluated by immunofluorescence analysis and with a colorimetric assay, respectively. The transactivation activity of NF-kappaB was assessed with a reporter gene assay. Sulfasalazine inhibited IL-1-induced collagen degradation by corneal fibroblasts in a concentration-dependent manner. It also inhibited the stimulatory effects of IL-1 on the synthesis or activation of various MMPs in a concentration-dependent manner. IL-1 induced the phosphorylation and degradation of IkappaB-alpha, the nuclear translocation and up-regulation of the DNA binding activity of the p65 subunit of NF-kappaB, and the activation of NF-kappaB in a manner sensitive to sulfasalazine. These results suggest that NF-kappaB contributes to the IL-1-induced degradation of collagen by corneal fibroblasts and is therefore a potential therapeutic target for treatment of corneal ulcers.

Mesh Headings (Keywords): Animals, Anti-Inflammatory Agents, Non-Steroidal, Cells, Cultured, Collagen, Cornea, Corneal Ulcer, DNA, Electrophoresis, Polyacrylamide Gel, Fibroblasts, Immunohistochemistry, Interleukin-1, Matrix Metalloproteinases, NF-kappa B, Rabbits, Receptors, Interleukin-1, Reverse Transcriptase Polymerase Chain Reaction, Sulfasalazine, Tissue Inhibitor of Metalloproteinases, Transfection


Check for Full Text / PubMed Unique Identifier (PMID): 16684522


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.